BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 26393798)

  • 1. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-20b promotes cell proliferation via targeting of TGF-β receptor II and upregulates MYC expression in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2017 Dec; 51(6):1842-1850. PubMed ID: 29039480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6.
    Zhang Z; Huang L; Yu Z; Chen X; Yang D; Zhan P; Dai M; Huang S; Han Z; Cao K
    DNA Cell Biol; 2014 Mar; 33(3):136-47. PubMed ID: 24383407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma.
    Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z
    Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.
    Parafioriti A; Bason C; Armiraglio E; Calciano L; Daolio PA; Berardocco M; Di Bernardo A; Colosimo A; Luksch R; Berardi AC
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
    Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
    Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.
    Liu Y; Yin B; Zhang C; Zhou L; Fan J
    Biochem Biophys Res Commun; 2012 Jan; 417(1):371-5. PubMed ID: 22155254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.
    De Vito C; Riggi N; Suvà ML; Janiszewska M; Horlbeck J; Baumer K; Provero P; Stamenkovic I
    PLoS One; 2011; 6(8):e23592. PubMed ID: 21853155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
    Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
    Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing's sarcoma cells.
    Tanaka K; Kawano M; Itonaga I; Iwasaki T; Miyazaki M; Ikeda S; Tsumura H
    Int J Oncol; 2016 Mar; 48(3):1135-44. PubMed ID: 26782922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.
    Dong Q; Meng P; Wang T; Qin W; Qin W; Wang F; Yuan J; Chen Z; Yang A; Wang H
    PLoS One; 2010 Apr; 5(4):e10147. PubMed ID: 20418948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs.
    Barbagallo C; Passanisi R; Mirabella F; Cirnigliaro M; Costanzo A; Lauretta G; Barbagallo D; Bianchi C; Pagni F; Castorina S; Granata A; Di Pietro C; Ragusa M; Malatino LS; Purrello M
    J Cell Physiol; 2019 Aug; 234(8):12625-12636. PubMed ID: 30515781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
    Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
    Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2.
    Huang F; Zhao H; Du Z; Jiang H
    Oncol Res; 2019 Feb; 27(3):293-299. PubMed ID: 29471894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth.
    Hameiri-Grossman M; Porat-Klein A; Yaniv I; Ash S; Cohen IJ; Kodman Y; Haklai R; Elad-Sfadia G; Kloog Y; Chepurko E; Feinmesser M; Issakov J; Sher O; Luria D; Kollender Y; Weizman A; Avigad S
    Oncotarget; 2015 Oct; 6(32):33834-48. PubMed ID: 26393682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.